The study examined survival in patients with difficult-to-treat infections caused by antibiotic-resistant bacteria in American hospitals. Despite the availability of newer antibiotics, patient mortality with these infections remains unacceptably high. It was found that patients often receive initial antibiotic treatment that proved ineffective in laboratory tests. Researchers emphasize that rapid identification of the specific pathogen and its antibiotic resistance pattern could be key to reducing mortality. Although a decrease in adjusted mortality was observed in patients with bloodstream infections caused by Pseudomonas aeruginosa over time, this patient group was small.